Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index; 7 of the 37 sources its claims cite were checked for support.
Abstract
Raf Kinase Inhibitory Protein (RKIP) maintains cellular robustness and prevents the progression of diseases such as cancer and heart disease by regulating key kinase cascades including MAP kinase and protein kinase A (PKA). Phosphorylation of RKIP at S153 by Protein Kinase C (PKC) triggers a switch from inhibition of Raf to inhibition of the G protein coupled receptor kinase 2 (GRK2), enhancing signaling by the β-adrenergic receptor (β-AR) that activates PKA. Here we report that PKA-phosphorylated RKIP promotes β-AR–activated PKA signaling. Using biochemical, genetic, and biophysical approaches, we show that PKA phosphorylates RKIP at S51, increasing S153 phosphorylation by PKC and thereby triggering feedback activation of PKA. The S51V mutation blocks the ability of RKIP to activate PKA in prostate cancer cells and to induce contraction in primary cardiac myocytes in response to the β-AR activator isoproterenol, illustrating the functional importance of this positive feedback circuit. As previously shown for other kinases, phosphorylation of RKIP at S51 by PKA is enhanced upon RKIP destabilization by the P74L mutation. These results suggest that PKA phosphorylation at S51 may lead to allosteric changes associated with a higher-energy RKIP state that potentiates phosphorylation of RKIP at other key sites. This allosteric regulatory mechanism may have therapeutic potential for regulating PKA signaling in disease states.
Overview
CoChat Summary
TL;DR
The paper identifies a positive feedback loop in which PKA-C phosphorylates RKIP at S51, enhancing PKC phosphorylation of RKIP at S153, inhibiting GRK2, up-regulating β-adrenergic receptor signaling, increasing cAMP, and further activating PKA. This loop potentiates PKA activity in prostate cancer cells and cardiac myocytes, and the authors propose S51 as a diagnostic marker and therapeutic target.
Key findings
- PKA-C phosphorylates RKIP primarily at S51 in vitro; S51V abolished detectable phosphorylation, S52V enhanced it, and S52E suppressed it. Table 1 reports WT Vmax 1,726 ± 126 pmol min−1 mg−1 and Km 38 ± 7 μM; S52V Vmax 9,852 ± 599 and Km 55 ± 7 μM; P74L Vmax 3,620 ± 163 and Km 17 ± 2 μM; G57K Vmax 1,020 ± 32 and Km 33 ± 3 μM.
- In PC-3 prostate cancer cells, isoproterenol increased S51 phosphorylation about twofold; anti-pS51 recognized RKIPWT but not S51V. S51 phosphorylation enhanced PKC phosphorylation at S153: S51V decreased pS153 after TPA, while S51E was phosphorylated at S153 with or without TPA. cAMP increased with RKIPWT plus isoproterenol and further with TPA, whereas S51V prevented optimal cAMP stimulation. PKA activity (pVASP) was potentiated by WT, blocked by S51V, and increased by S51E with isoproterenol without added TPA; H89 suppressed VASP phosphorylation.
- In cardiac myocytes, S51V reduced PKC phosphorylation at S153 and suppressed the isoproterenol response; S51V also reduced contractile activity to control levels upon isoproterenol relative to RKIPWT (WT + PMA vs. V51 + PMA: P = 0.0178; WT + ISO vs. V51 + ISO: P = 0.0016; contractility from 20 replicates of five independent experiments, *P < 0.01 vs. Con-Iso and #P < 0.0001 as indicated).
- BLI showed RKIPWT binds apo PKA-C with Kd ≈ 36 μM and ATPγN-saturated PKA-C with Kd ≈ 6 μM, a sixfold enhancement (Table 2: 36.4 ± 0.7 μM vs. 6.2 ± 0.7 μM; cooperativity σ = 6). NMR chemical shift perturbations mapped RKIP residues near S51 and one face of RKIP, with long-range effects at Q183 and L180; P74L showed a similar CSP profile, and G57K reduced Vmax by almost 50%. PKA-C interface changes involved the Gly-rich, catalytic, DFG, and activation loops, similar to PKI but attenuated.
Methods
- In vitro kinase assays used recombinant PKA-C and rat RKIP mutants, with site-directed mutagenesis, phospho-imaging, and immunoblotting; a pS51-specific antibody was generated and purified against a phosphopeptide.
- Cell experiments used PC-3 prostate cancer cells depleted of endogenous RKIP by shRNA and reconstituted with vector, RKIPWT, RKIPS51V, or RKIPS51E, then treated with isoproterenol, TPA, H89, or BIS; readouts included pS51, pS153, cAMP ELISA, and pVASP PKA activity. Cardiac myocytes were adenovirally transduced with WT or S51V RKIP, and contractility was measured.
- Biophysical characterization used biolayer interferometry with apo and ATPγN-saturated PKA-C and NMR HSQC/TROSY titrations with 15N-labeled RKIP and PKA-C to map binding interfaces.
Limitations
- Stated in the paper: more in-depth analyses are required to elucidate the detailed molecular mechanism by which S51 phosphorylation potentiates S153 phosphorylation; the interaction studies do not fully explain this. The authors also state that whether RKIP generates discrete PKA outputs or fine-tunes homeostatic control requires further analysis, and that ATPγN’s lower affinity/cooperativity may explain discrepancies between in vitro binding studies and in-cell assays.
- Evident from the text: mechanistic work relies on recombinant proteins, PC-3 cells, and cardiac myocytes rather than in vivo disease models or human tissue validation. The S51E phosphomimetic is an approximation of phosphorylation, and the paper does not provide a structure of S51-phosphorylated RKIP or direct PKC-binding measurements.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Fig. 4. NMR map of the residues of RKIPWT and P74L mutant involved in PKA-C/RKIP interaction interface. (A and B) [1H,15N]-HSQC spectra showing the backbone chemical shift changes of selected resonances of (A) RKIPWT and (B) RKIPP74L upon titration of increasing amount of PKA-C/ATPγN complex. (C) CSP of the amide fingerprint of RKIPWT and RKIPP74L mutant alone (Δδfree) and in a 1:2 complex with PKA-C/ATPγN (Δδbound) vs. residues, calculated using Eq. 1. The residues that show a CSP value two times greater than 1 SD from the average CSP (gray dashed line) are indicated in the histogram. (D–G) Cartoon (D) and surface (E) mapping of the amide CSP of RKIPWT or cartoon (F) and surface (G) of P74L mutant onto the three-dimensional structure (Protein Data Bank [PDB] ID 2IQY). The cartoons and the surfaces are colored according the CSP values ranging from 0.015 to 0.15 ppm.](https://figures.cochat.ai/paper-figures/fcc4ecebf9f848e7baaf3ee1620c03c7/raf-kinase-inhibitory-protein-regulates-the-camp-dependent-protein-kinase-figure-4.jpg)
![Fig. 5. NMR mapping of the PKA-C residues involved in the PKA-C/RKIP interactions. (A) CSPs of the PKA-C/ATPγN fingerprint upon interaction with RKIPWT (black) and PKI. The shaded colors indicate the Gly-rich loop (green), catalytic loop (yellow), DFG loop (orange), activation loop (purple), P + 1 loop (blue), and APE (red). (B) Chemical shift changes mapped onto the PKA-C structure (PDB ID 4wb5). The hot pink spheres highlight residues that broaden out, while the orange spheres indicate those residues that sharpened out upon interacting with RKIPWT. (C) [1H,15N]-TROSY-HSQC spectra overlay for specific residues of PKA-C in complex with ATPγN (orange), ATPγN/RKIP (purple), and ATPγN/PKI (green).](https://figures.cochat.ai/paper-figures/52de2215e4ef4e178a30f6cffb39742f/raf-kinase-inhibitory-protein-regulates-the-camp-dependent-protein-kinase-figure-5.jpg)
Verification
Claims the paper makes
3 Valid · 0 Not valid · 17 Not checked · 72 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The amide fingerprint of PKA-C changes significantly upon nucleotide and RKIPWT binding (23–25).”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > Biolayer Interferometry and NMR Confirm the Binding Interaction between RKIP and PKA.
What the sources say
- Not checked yetcites [23] L. R. Masterson, A. Mascioni, N. J. Traaseth, S. S. Taylor, G. Veglia, Allosteric cooperativity in protein kinase A. Proc. Natl. Acad. Sci. U.S.A. 105, 506– 511 (2008). 18178622 PMC2206566 source
A check is scheduled.
- Not checked yetcites [24] L. R. Masterson, Dynamics connect substrate recognition to catalysis in protein kinase A. Nat. Chem. Biol. 6, 821– 828 (2010). 20890288 PMC3487389 source
A check is scheduled.
- Partly supportedcites [25] C. Olivieri, Multi-state recognition pathway of the intrinsically disordered protein kinase inhibitor by protein kinase A. eLife 9, 9 (2020). PMC7234811 32338601 sourceExperimental — accuracy not yet measured
The Results subsection 'PKA-C binding rigidifies the PSS motif and stabilizes HAR and NES helices of PKIα' states that the amide fingerprint of the kinase changes significantly upon nucleotide (ATPγN) binding (Figure 3C), with additional changes on binding the inhibitor, so the nucleotide half of the claim is supported. However, our copy nowhere mentions RKIP or RKIPWT — the binding partner studied here is the intrinsically disordered inhibitor PKIα (searched: RKIP, Raf kinase inhibitory protein, chemical shift perturbation of PKA-C), so the 'RKIPWT binding' part attributed to this source is not supported by it. Because the citing sentence carries references 23–25, the RKIP element presumably belongs to another work in that group, not to Olivieri et al. 2020. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Overall, the RKIP CSP profile revealed a typical trend observed for substrates and pseudosubstrates of the kinase (22, 24–26).”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > Biolayer Interferometry and NMR Confirm the Binding Interaction between RKIP and PKA.
What the sources say
- Partly supportedcites [22] Y. Wang, Globally correlated conformational entropy underlies positive and negative cooperativity in a kinase’s enzymatic cycle. Nat. Commun. 10, 799 (2019). 30778078 PMC6379427 sourceExperimental — accuracy not yet measured
Our copy never mentions RKIP: searches for 'RKIP' returned only method/analysis passages, so the RKIP-specific part of the sentence (that its CSP profile follows the trend) is not this paper's observation. What the source does supply is the general trend the citation is offered for — the CONCISE/chemical-shift mapping of PKA-C with a substrate versus a pseudosubstrate peptide (Results, 'Agreement of calorimetric and NMR-derived PKA-C energy landscape': PKS5–24 shifts the kinase toward the closed/Michaelis state in a more coordinated fashion than PKI5–24; Discussion: other peptide substrates bind more weakly and the equilibrium does not shift fully closed). Thus the background 'typical trend for substrates and pseudosubstrates of the kinase' is supported, while the attribution of RKIP's CSP profile to this source is not. (LLM, conf=0.68)
- Could not verifycites [24] L. R. Masterson, Dynamics connect substrate recognition to catalysis in protein kinase A. Nat. Chem. Biol. 6, 821– 828 (2010). 20890288 PMC3487389 sourceExperimental — accuracy not yet measured
Our copy of Masterson et al. (2010) characterises PKA-C substrate recognition with spin-relaxation parameters (R1, R2, Rex, H-X NOE), ITC and X-ray crystallography, and the only chemical-shift-based analysis is Rex plotted against the squared chemical-shift difference (Δω²) between apo and ligand-bound states (Results, 'Dynamics are synchronous with slow step of catalysis'). No passage reports a chemical shift perturbation (CSP) profile or a 'typical trend' for substrates versus pseudosubstrates/inhibitors; the pseudosubstrate-like inhibitor PKI5-24 is mentioned only in the Discussion regarding crystallographic ordering and induced fit. Searched: 'chemical shift perturbation / CSP', 'pseudosubstrate PKI inhibitor peptide binding chemical shifts', 'substrate peptide titration backbone amide shifts'. (LLM, conf=0.68)
- Partly supportedcites [25] C. Olivieri, Multi-state recognition pathway of the intrinsically disordered protein kinase inhibitor by protein kinase A. eLife 9, 9 (2020). PMC7234811 32338601 sourceExperimental — accuracy not yet measured
Our copy supports the pseudosubstrate half of the attribution: the Results section 'PKA-C binding rigidifies the PSS motif...' and the Figure 3 legend state that PKIα residues undergoing significant CSPs are localized in the HAR and PSS motifs, i.e. within the substrate-binding site of PKA-C, while the rest of the peptide is largely unaffected. The Discussion adds that most PKA target substrates lack the HAR motif and are recognized only through the highly positively charged consensus sequence in the PSS-like motif, which molds into the binding groove from a disordered region. However, the paper reports no chemical-shift-perturbation profiles of actual PKA substrates and never frames the CSP pattern as 'a typical trend observed for substrates and pseudosubstrates'; that generalization (and the substrate arm of the claim) is not stated in this source, so it rests on the other co-cited references (22, 25, 26). (LLM, conf=0.68)
- Could not verifycites [26] C. Olivieri, Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A. Commun. Biol. 4, 321 (2021). 33692454 PMC7946884 sourceExperimental — accuracy not yet measured
Our copy of Olivieri et al. (2021) contains no mention of RKIP anywhere: the CSP/NMR work (Results, 'The J-domain disrupts the internal allosteric network of PKA-CDNAJB1'; Methods, 'NMR spectroscopy' and 'Chemical shift analyses') is limited to PKA-CWT and PKA-CDNAJB1 titrated with ATPγN, ADP and the pseudosubstrate PKI5–24, and the substrate work (Methods 'Sample preparation of peptides', 'Enzyme assays'; Results, Fig. 2) involves only Kemptide, CREB and KSR1 as kinetic peptides, not as CSP ligands. So the paper does describe CSPs of a pseudosubstrate (PKI5–24 binding propagating effects from the substrate-binding sites to both lobes), but it never reports an RKIP CSP profile, and it does not credit that observation to another named work either. Searches run: 'RKIP', 'RKIP phosphatase inhibitor protein binding to PKA catalytic subunit NMR titration', 'typical CSP trend for substrates and pseudosubstrates', 'Kemptide CREB KSR1 substrate peptide binding chemical shift perturbations'. (LLM, conf=0.65)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This effect is due to the K-type positive cooperativity between nucleotide and substrate typical of PKA-C (21, 22).”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > Biolayer Interferometry and NMR Confirm the Binding Interaction between RKIP and PKA.
What the sources say
- Supportedcites [21] J. Kim, G. Li, M. A. Walters, S. S. Taylor, G. Veglia, Uncoupling catalytic and binding functions in the cyclic AMP-dependent protein kinase A. Structure 24, 353– 363 (2016). 26833386 PMC4775281 source
The RESULTS section ('Different nucleotides provide varying degree of binding cooperativity') states that saturation with nucleotides increases PKI5-24 affinity and quantifies this as K-type cooperativity (σ), with ATPγN giving a positive σ = 53 in the series adenine < adenosine < ADP < ATPγN ≪ ATP. The DISCUSSION frames this as the positive K-type allosteric binding cooperativity characteristic of PKA-C (contrasting Src kinase's negative cooperativity), so the citing sentence's attribution of the ATPγN-dependent affinity enhancement to K-type positive cooperativity typical of PKA-C is supported. The only caveat is that our copy stresses ATPγN's cooperativity is dramatically reduced relative to ATP (σ = 400), but it remains positive, which the claim does not deny. (LLM, conf=0.88)
- Supportedcites [22] Y. Wang, Globally correlated conformational entropy underlies positive and negative cooperativity in a kinase’s enzymatic cycle. Nat. Commun. 10, 799 (2019). 30778078 PMC6379427 source
The Introduction (p. 5) states 'PKA-C binds nucleotide and unphosphorylated substrate via positive K-type cooperativity, while the phosphorylated substrate and ADP display a negative binding cooperativity,' and the Results section 'Agreement of calorimetric and NMR-derived PKA-C energy landscape' explains that 'These two binding events exhibit positive K-type cooperativity, wherein binding of the nucleotide or substrate increases the affinity of the enzyme for the second ligand.' The same Results section quantifies the ATPγN-dependent enhancement: 'ATPγN or ATPγC saturated kinase binds PKS5–24 with higher affinity than the apo form with σ of 2.8 and 4.4, respectively.' Thus the source supports both the affinity enhancement upon ATPγN saturation and its attribution to K-type positive cooperativity characteristic of PKA-C. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Stimulation of PC-3 cells expressing RKIPWT with isoproterenol, which activates the β-AR, increased S51 phosphorylation by about twofold as shown by Western blotting with the anti-pS51 antibody (Fig. 1D).”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > RKIP Is Phosphorylated at S51 in Cells upon PKA Activation.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“expression of RKIPS51V reduced cardiac myocyte contractile activity to control levels upon isoproterenol stimulation relative to RKIPWT (Fig. 3C).”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > RKIP Phosphorylation at S51 Enhances PKA Activity in Prostate Cancer Cells and Cardiomyocytes.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
54 more claims
Create a free account to see all 92 claims and to verify the 30 references still open.
- It may state two separate claims as one. 18
- Probably not a substantial claim. 18
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, the phosphorylation of RKIP by PKA-C at Ser51 and its involvement in regulating the β-adrenergic receptor signaling cascade.[22]”
From Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein (2025) · cites this paper as [22]
In the citing paper
“The phosphorylation of RKIP by PKA-C at Ser51 has been shown to affect its function as a signaling regulator.[22]”
From Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein (2025) · cites this paper as [22]
In the citing paper
“We previously found that RKIP binds to PKA-C with a dissociation constant of approximately 6 μM in the presence of Mg2+ ions and nucleotide.[22]”
From Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein (2025) · cites this paper as [22]
In the citing paper
“In our previous work, we established a foundational understanding of how PKA-C phosphorylates RKIP using cell-based experiments and by mapping the NMR chemical shift changes of both proteins during their interaction.[22]”
From Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein (2025) · cites this paper as [22]
In the citing paper
“We found that most of the RKIP amide resonances that exhibited perturbation were localized near the recognition sequence for the kinase, with the most significant changes observed for residues S51, G57, and L58. Additionally, residues V154 and Q22, which are located close to the phosphorylation loop, were also affected.[22]”
From Protein Kinase A Phosphorylates a Conformationally High-energy State of Raf Kinase Inhibitory Protein (2025) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > RKIP Phosphorylation at S51 Enhances PKA Activity in Prostate Cancer Cells and Cardiomyocytes.
“We further tested the effect of blocking PKA phosphorylation of RKIP in primary mouse cardiac myocytes.”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Materials and Methods > Neonatal Cardiomyocytes and Assessment of Cardiomyocyte Contractility.
“Neonatal rat cardiomyocytes were isolated as described previously (31).”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > PKA Phosphorylates RKIP at S51 In Vitro.
“The Michaelis constant (Km) for RKIPWT was ∼20 μM.”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > PKA Phosphorylates RKIP at S51 In Vitro.
“| WT | 1,726 ± 126 | 38 ± 7 |”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > RKIP Phosphorylation at S51 in Cells Enhances PKC Phosphorylation at S153.
“These cells were serum-starved to reduce background kinase activity and then treated with tetradecanoyl phorbol acetate (TPA) for 5 min to activate PKC.”
§ Raf Kinase Inhibitory Protein regulates the cAMP-dependent protein kinase signaling pathway through a positive feedback loop > Results > RKIP Phosphorylation at S51 in Cells Enhances PKC Phosphorylation at S153.
“For A–E, PC-3 cells stably expressing RKIP shRNA were transfected with control vector (VC), WT, or mutant RKIP (S51V, S51E) and serum-starved for 20 h before stimulation using TPA for 30 min, isoproterenol (Iso) for 10 min, or H89 for 30 min as indicated.”
Citations
Cites
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
Delaglio, F., Grzesiek, S., Vuister, G., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,965
Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy
Bodenhausen, G., & Ruben, D. J. (1980) · Chemical Physics Letters · doi:10.1016/0009-2614(80)80041-8 · Cited by 2,563
NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy
Lee, W., Tonelli, M., & Markley, J. L. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu830 · Cited by 2,045
Using chemical shift perturbation to characterise ligand binding
Williamson, M. P. (2013) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2013.02.001 · Cited by 1,460
Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K. D., Rose, D. W., Mischak, H., et al. (1999) · Nature · doi:10.1038/43686 · Cited by 893
Interlinked Fast and Slow Positive Feedback Loops Drive Reliable Cell Decisions
Brandman, O., Ferrell, J. E., Li, R., & Meyer, T. (2005) · Science · doi:10.1126/science.1113834 · Cited by 466
Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2
Lorenz, K., Lohse, M. J., & Quitterer, U. (2003) · Nature · doi:10.1038/nature02158 · Cited by 384
Self-citationRaf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7
Dangi‐Garimella, S., Yun, J., Eves, E. M., Newman, M., Erkeland, S. J., Hammond, S. M., Minn, A. J., & Rosner, M. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.294 · Cited by 363
Self-citationCorbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., & Rosner, M. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210015200 · Cited by 360
Self-citationHoffert, J. D., Pisitkun, T., Wang, G., Shen, R.-F., & Knepper, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600895103 · Cited by 345
PKA: Lessons learned after twenty years
Taylor, S. S., Zhang, P., Steichen, J. M., Keshwani, M. M., & Kornev, A. P. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.03.007 · Cited by 297
Phosphorylation of the Vasodilator-stimulated Phosphoprotein Regulates Its Interaction with Actin
Harbeck, B., Hüttelmaier, S., Schlüter, K., Jockusch, B. M., & Illenberger, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005066200 · Cited by 255
Fluorescent Proteins as Proteomic Probes
Cristea, I. M., Williams, R., Chait, B. T., & Rout, M. P. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500227-mcp200 · Cited by 251
Dynamics connect substrate recognition to catalysis in protein kinase A
Masterson, L. R., Cheng, C., Yu, T., Tonelli, M., Kornev, A., Taylor, S. S., & Veglia, G. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.452 · Cited by 216
Self-citationSignalling pathway for RKIP and Let‐7 regulates and predicts metastatic breast cancer
Yun, J., Frankenberger, C. A., Kuo, W., Boelens, M. C., Eves, E. M., Cheng, N., Liang, H., Li, W., Ishwaran, H., Minn, A. J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.312 · Cited by 206
Self-citationAllosteric cooperativity in protein kinase A
Masterson, L. R., Mascioni, A., Traaseth, N. J., Taylor, S. S., & Veglia, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709214104 · Cited by 189
Self-citationAdams, J. A., & Taylor, S. S. (1992) · Biochemistry · doi:10.1021/bi00151a019 · Cited by 188
Pidoux, G., & Taskén, K. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0010 · Cited by 184
Fu, Z., Kitagawa, Y., Shen, R., Shah, R., Mehra, R., Rhodes, D., Keller, P. J., Mizokami, A., Dunn, R., Chinnaiyan, A. M., et al. (2006) · The Prostate · doi:10.1002/pros.20319 · Cited by 160
Zhao, J., O'Donnell, V. B., Balzar, S., St. Croix, C. M., Trudeau, J. B., & Wenzel, S. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018075108 · Cited by 143
Raf Kinase Inhibitory Protein Regulates Raf-1 but Not B-Raf Kinase Activation
Trakul, N., Menard, R. E., Schade, G. R., Qian, Z., & Rosner, M. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413929200 · Cited by 110
Self-citationSuppression of anti-TROSY lines in a sensitivity enhanced gradient selection TROSY scheme
Nietlispach, D. (2005) · Journal of Biomolecular NMR · doi:10.1007/s10858-004-8195-7 · Cited by 85
Phosphorylation of GRK2 by Protein Kinase C Abolishes Its Inhibition by Calmodulin
Krasel, C., Dammeier, S., Winstel, R., Brockmann, J., Mischak, H., & Lohse, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008773200 · Cited by 82
Yonemoto, W., Garrod, S. M., Bell, S. M., & Taylor, S. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46675-0 · Cited by 79
cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban
Masterson, L. R., Yu, T., Shi, L., Wang, Y., Gustavsson, M., Mueller, M. M., & Veglia, G. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.06.041 · Cited by 76
Self-citationDemirkan, G., Yu, K., Boylan, J. M., Salomon, A. R., & Gruppuso, P. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021729 · Cited by 71
Walker, C., Wang, Y., Olivieri, C., Karamafrooz, A., Casby, J., Bathon, K., Calebiro, D., Gao, J., Bernlohr, D. A., Taylor, S. S., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw9298 · Cited by 71
Self-citationCardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy
Schmid, E., Neef, S., Berlin, C., Tomasovic, A., Kahlert, K., Nordbeck, P., Deiss, K., Denzinger, S., Herrmann, S., Wettwer, E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3972 · Cited by 65
Self-citationMolecular mechanisms of feedback inhibition of protein kinase A on intracellular cAMP accumulation
Vandamme, J., Castermans, D., & Thevelein, J. M. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.04.001 · Cited by 64
Wang, Y., V.S., M., Kim, J., Li, G., Ahuja, L. G., Aoto, P., Taylor, S. S., & Veglia, G. (2019) · Nature Communications · doi:10.1038/s41467-019-08655-7 · Cited by 59
Self-citationGranovsky, A. E., Clark, M. C., McElheny, D., Heil, G., Hong, J., Liu, X., Kim, Y., Joachimiak, G., Joachimiak, A., Koide, S., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01271-08 · Cited by 48
Self-citationTargeting Raf Kinase Inhibitory Protein Regulation and Function
Yesilkanal, A. E., & Rosner, M. R. (2018) · Cancers · doi:10.3390/cancers10090306 · Cited by 48
Self-citationConserved salt-bridge competition triggered by phosphorylation regulates the protein interactome
Skinner, J. J., Wang, S., Lee, J., Ong, C., Sommese, R., Sivaramakrishnan, S., Koelmel, W., Hirschbeck, M., Schindelin, H., Kisker, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711543114 · Cited by 47
Self-citationLimited inhibition of multiple nodes in a driver network blocks metastasis
Yesilkanal, A. E., Yang, D., Valdespino, A., Tiwari, P., Sabino, A. U., Nguyen, L. C., Lee, J., Xie, X.-H., Sun, S., Dann, C., et al. (2021) · eLife · doi:10.7554/elife.59696 · Cited by 34
Self-citationMurthy, K. S., Mahavadi, S., Huang, J., Zhou, H., & Sriwai, W. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00229.2007 · Cited by 33
RKIP Structure Drives Its Function: A Three-State Model for Regulation of RKIP
Skinner, J. J., & Rosner, M. R. (2014) · Critical Reviews in Oncogenesis · doi:10.1615/critrevoncog.2014012001 · Cited by 32
Self-citationOlivieri, C., Wang, Y., Li, G. C., V S, M., Kim, J., Stultz, B. R., Neibergall, M., Porcelli, F., Muretta, J. M., Thomas, D. D., et al. (2020) · eLife · doi:10.7554/elife.55607 · Cited by 32
Self-citationWright, K. T., & Vella, A. T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203486 · Cited by 27
Olivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Self-citationLorenz, K., Rosner, M. R., Brand, T., & Schmitt, J. P. (2017) · The Journal of Physiology · doi:10.1113/jp274064 · Cited by 26
Self-citationUncoupling Catalytic and Binding Functions in the Cyclic AMP-Dependent Protein Kinase A
Kim, J., Li, G., Walters, M. A., Taylor, S. S., & Veglia, G. (2016) · Structure · doi:10.1016/j.str.2015.11.016 · Cited by 25
Self-citationAnalysis of DNA variations in promoter region of HCNP gene with Alzheimer’s disease
Okita, K., Matsukawa, N., Maki, M., Nakazawa, H., Katada, E., Hattori, M., Akatsu, H., Borlongan, C. V., & Ojika, K. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.037 · Cited by 15
Research works printed but not linked: 1
- D. Goddard, D. G. Kneller, Sparky 3 (University of California, San Francisco, 2004).
Cited by
AI-designed NMR spectroscopy RF pulses for fast acquisition at high and ultra-high magnetic fields
Manu, V. S., Olivieri, C., & Veglia, G. (2023) · Nature Communications · doi:10.1038/s41467-023-39581-4 · Cited by 35
Self-citationCross-Talks between RKIP and YY1 through a Multilevel Bioinformatics Pan-Cancer Analysis
Baritaki, S., & Zaravinos, A. (2023) · Cancers · doi:10.3390/cancers15204932 · Cited by 22
Chronic β-adrenergic stress contributes to cardiomyopathy in rodents with collagen-induced arthritis
Zhu, Z.-D., Zhang, M., Wang, Z., Jiang, C., Huang, C.-J., Cheng, H., Guan, Q.-Y., Su, T., Wang, M., Gao, Y., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01099-2 · Cited by 16
Yang, X., Mao, Q., & Wang, B. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00750 · Cited by 15
Wei, Y., Liao, M., Chen, Y., Xue, R., Shi, X., Liu, D., Zhuo, F.-F., Tang, H., Lu, Z., Tu, P., et al. (2022) · Chemical Communications · doi:10.1039/d2cc05440j · Cited by 12
Metadata
- Authors
- Lee, J., Olivieri, C., Ong, C., Masterson, L. R., Gomes, S., Lee, B.-S., Schaefer, F., Lorenz, K., Veglia, G., & Rosner, M. R.
- Affiliations
- University of Chicago (US)
- University of Minnesota (US)
- George Washington University (US)
- University of Würzburg (DE)
- Corresponding author
- Veglia, Gianluigi
- Rosner, Marsha Rich
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2022-06-13
- Volume
- 119
- Issue
- 25
- Pages
- e2121867119-e2121867119
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC9231499
- OpenAlex
- W4282582314
- Semantic Scholar
- 5857ad8b2ed5d61125c752ba2dec677c8c9eaf1b
- Cited by
- 20
- References
- 42
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 2 · 2023: 3 · 2022: 3
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Knowledge@UChicago (University of Chicago) (submittedVersion, cc-by-nc-nd)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- University of Chicago (cc-by-nc-nd)
- Funders
- HHS | NIH | National Institute of General Medical Sciences (GM087630, GM121735, GM100310)
- Deutsche Forschungsgemeinschaft (SFB1116/A09, SFB/TR296/P10)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Keywords
- RKIP, protein kinase A, positive feedback loop, protein kinase A phosphorylation, protein kinase C, allosteric regulation, beta-adrenergic signaling, G protein-coupled receptor kinase 2, prostate cancer, cardiac myocyte contraction, isoproterenol
- MeSH terms
- PC-3 Cells, Humans, Male, Phosphorylation, Prostatic Neoplasms, Protein Kinase C, Signal Transduction, Cyclic AMP-Dependent Protein Kinases, Feedback, Physiological, Phosphatidylethanolamine Binding Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.